Top

Published in:

Open Access 01-08-2021 | Arthritis | Case Based Review

Post-COVID-19 arthritis: a case report and literature review

Authors: M. Gasparotto, V. Framba, C. Piovella, A. Doria, Luca Iaccarino

Published in: Clinical Rheumatology | Issue 8/2021

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers and clinicians are exploring the pathogenetic mechanisms of the viral-induced damage and growing interest is focusing on the short-term and long-term immune-mediated consequences triggered by the infection. We will focus on post-SARS-CoV2 infection arthritis which may arise as a new pathological condition associated with COVID-19. In this article, we describe a case of acute oligoarthritis occurring 13 days after a SARS-CoV2 severe pneumonia in a middle-aged Caucasian man and we go over a brief review of the current available literature. We hypothesize that molecular mimicry might be the basic immunological mechanism responsible for the onset of COVID-19-related arthritis based on the current knowledge of SARS-CoV2 and on the known pathogenetic mechanism of viral-induced arthritis.

Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, Navalesi P, Simioni P (2020) COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 120:998–1000. https://doi.org/10.1055/s-0040-1710018CrossRefPubMedPubMedCentral

Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173:268–277. https://doi.org/10.7326/M20-2003CrossRefPubMed

McGonagle D, Sharif K, O’Regan A et al (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19:102537. https://doi.org/10.1016/j.autrev.2020.102537CrossRefPubMedPubMedCentral

Bindoli S, Felicetti M, Sfriso P, Doria A (2020) The amount of cytokine-release defines different shades of Sars-Cov2 infection. Exp Biol Med 245:1–7. https://doi.org/10.1177/1535370220928964CrossRef

Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O, Hoyt KJ, Han J, Grom AA, Gattorno M, Ravelli A, Benedetti F, Behrens EM, Cron RQ, Nigrovic PA (2020) On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheum 72:1059–1063. https://doi.org/10.1002/art.41285CrossRef

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, Nguyen EL, Barsh GR, Maskatia S, Mathew R (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540. https://doi.org/10.1542/hpeds.2020-0123CrossRefPubMed

Viner RM, Whittaker E (2020) Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 395:1741–1743. https://doi.org/10.1016/S0140-6736(20)31129-6CrossRefPubMedPubMedCentral

Harzallah I, Debliquis A, Drénou B (2020) Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost 18:2064–2065. https://doi.org/10.1111/jth.14867CrossRefPubMed

Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, Torre-Espi M, Colmenero I, Torrelo A (2020) Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 37:406–411. https://doi.org/10.1111/pde.14215CrossRefPubMed

10.

Yokogawa N, Minematsu N, Katano H, Suzuki T (2020) Case of acute arthritis following SARS-CoV2 infection. Ann Rheum Dis 0:1. https://doi.org/10.1136/annrheumdis-2020-218281

11.

Liew IY, Mak TM, Cui L, Vasoo S, Lim XR (2020) A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol 26:233. https://doi.org/10.1097/RHU.0000000000001560CrossRefPubMed

12.

Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, Komagata Y, Kaname S (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https://doi.org/10.1136/rmdopen-2020-001350CrossRefPubMedPubMedCentral

13.

Saricaoglu EM, Hasanoglu I, Guner R (2020) The first reactive arthritis case associated with COVID-19 [Online ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.26296

14.

Danssaert Z, Raum G, Hemtasilpa S (2020) Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus 12:e9698. https://doi.org/10.7759/cureus.9698CrossRefPubMedPubMedCentral

15.

Parisi S, Borrelli R, Bianchi S, Fusaro E (2020) Viral arthritis and COVID-19. Lancet Rheumatol 2:e655–e657. https://doi.org/10.1016/S2665-9913(20)30348-9CrossRefPubMedPubMedCentral

16.

Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19:80–94. https://doi.org/10.1128/CMR.19.1.80-94.2006CrossRefPubMedPubMedCentral

17.

Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 42:102–111. https://doi.org/10.1007/s12016-011-8294-7CrossRefPubMed

18.

Cappello F (2020) Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Cell Stress Chaperones 25:381–382. https://doi.org/10.1007/s12192-020-01112-1CrossRefPubMedPubMedCentral

19.

Cappello F, Marino Gammazza A, Dieli F, Conway de Macario E, Macario AJL (2020) Does SARS-CoV-2 trigger stress-induced autoimmunity by molecular mimicry? A hypothesis. J Clin Med 9:2038. https://doi.org/10.3390/jcm9072038CrossRefPubMedCentral

20.

Angileri F, Legare S, Marino Gammazza A, Conway de Macario E, JL Macario A, Cappello F (2020) Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev 19:102591. https://doi.org/10.1016/j.autrev.2020.102591CrossRefPubMedPubMedCentral

21.

Hwa KY, Lin WM, Hou YI, Yeh TM (2008) Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. J Biomed Biotechnol 2008:326464–326468. https://doi.org/10.1155/2008/326464CrossRefPubMedPubMedCentral

22.

Tim Chew F, Ong SY, Hew CL (2003) Severe acute respiratory syndrome coronavirus and viral mimicry. Lancet 361:2081. https://doi.org/10.1016/S0140-6736(03)13652-5CrossRefPubMedCentral

23.

Lucchese G, Flöel A (2020) Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev 19:102556. https://doi.org/10.1016/j.autrev.2020.102556CrossRefPubMedPubMedCentral

24.

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med 382:2574–2576. https://doi.org/10.1056/NEJMc2009191CrossRefPubMed

25.

Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S et al (2020) Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 95:e601–e605. https://doi.org/10.1212/WNL.0000000000009619CrossRefPubMed

26.

Ibáñez S, Martínez O, Valenzuela F, Silva F, Valenzuela O (2020) Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Clin Rheumatol 39(8):2461–2465. https://doi.org/10.1007/s10067-020-05202-4CrossRefPubMed

27.

James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain M, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB (2007) Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16(6):401–409. https://doi.org/10.1177/0961203307078579CrossRefPubMed

28.

Schrezenmeier E, Dörner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16:155–166. https://doi.org/10.1038/s41584-020-0372-xCrossRefPubMed

29.

Marks M, Marks JL (2016) Viral arthritis. Clin Med (Lond) 16:129–134. https://doi.org/10.7861/clinmedicine.16-2-129CrossRef

Title: Post-COVID-19 arthritis: a case report and literature review
Authors: M. Gasparotto
V. Framba
C. Piovella
A. Doria
Luca Iaccarino
Publication date: 01-08-2021
Publisher: Springer International Publishing
Keywords: Arthritis
SARS-CoV-2
Reactive Arthritis
COVID-19
Post-COVID Syndrome
Published in: Clinical Rheumatology / Issue 8/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05550-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2021

HLA-subtypes B*27 and ankylosing spondylitis features comments on Fellahi’s article “Are early onset of disease and uveitis affected by HLA- subtypes B*27 in ankylosing spondylitis?”

Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis

Effect of plasma exosomes on endothelial cell tight junction proteins in SLE patients with immune thrombocytopenia

Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey

Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease

Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials

HLA-subtypes B27 and ankylosing spondylitis features comments on Fellahi’s article “Are early onset of disease and uveitis affected by HLA- subtypes B27 in ankylosing spondylitis?”